Effect of magnesium on poly cystic ovary syndrome

Not Applicable

Recruiting

Conditions: poly cystic ovary syndrome.
Polycystic ovarian syndrome
E28.2

Registration Number: IRCT20130903014551N9

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 70

Inclusion Criteria

Women 18 to 45 years old with PCOS
BMI between 5/18 to 30
Do not change the dose of the drug or start taking a new drug in the last two weeks
Absence of menopause
Absence of hypothyroidism
Do not take vitamin and mineral supplements

Exclusion Criteria

Failure to follow nutritional recommendations and interventions
Failure to refer the person in the next steps
Change the dose of the drug or start taking a new drug that affects the indicators of the study
Having a specific disease that disrupts the study process
Occurrence of menopause

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Menstrual disorder. Timepoint: Before and after intervention. Method of measurement: Based on standard definitions provided by the International Federation of Gynecology and Obstetrics.;Androgenic alopecia. Timepoint: Before and after intervention. Method of measurement: Sinclair Scale.;Quality of life. Timepoint: Before and after intervention. Method of measurement: Health Survey Questionnaire (SF-36.;Acne. Timepoint: Before and after intervention. Method of measurement: GAGS (global acne grading system) method.;Number of ovarian cysts. Timepoint: At the beginning and end of the intervention. Method of measurement: sonography.

Secondary Outcome Measures

Name	Time	Method
Physical activity. Timepoint: In the second,forth,sixth,eighth and tenth weeks. Method of measurement: Physical activity record questionnaire.;Dietary intake. Timepoint: In the second,forth,sixth,eighth and tenth weeks. Method of measurement: food record.;Serum magnesium concentration. Timepoint: At the beginning the intervention, In the fifth week of the intervention. Method of measurement: AAS method.